Company Overview and News

2
CANADA STOCKS-TSX at three-month low as trade worries weigh

2018-09-11 reuters
Sept 11 (Reuters) - Canada’s main stock index touched over three-month lows on Tuesday led by declines in materials companies amid the ongoing Sino-U.S. trade dispute and uncertainty over the future of NAFTA trade pact.
FR OMI IMO ABX OMI ACBFF NPIFF IMO SU NPI OROXF RNX RNX.WT ACB RNKLF CNQ BRPIF FQVLF AG FQM ABX SU

41
Sector Allocations

2018-09-03 seekingalpha - 2
This is a follow-up to my August 20, 2018 article, which included a portfolio review, but not sector information. (Note to non-PRO subscribers: I've avoided writing single ticker articles to prevent them from being paywalled, but SA made the dual-ticker August 20 article an Editor's Pick and paywalled it. C'est la vie.)
SOJA VT TXN RDSB RDSA IMO AAPL DOV GSK RYDAF INTC ORCL LEG SO DUKH IMO RDS.B GEC GE RDS.A DUK GSK MFC BLK TGT 0945 CVX RYDBF GNE MFC MSFT OXY

 
Imperial Oil vows to employ oilsands technology to cut GHG intensity by 10%

2018-08-28 cbc.ca
Imperial Oil Ltd. is pledging to cut its oilsands greenhouse gas emissions per barrel by 10 per cent over the next five years as it ramps up production and works to get in line with increasingly stringent environmental regulation.
IMO IMO

1
Canada Crude Differential Seen Staying High As Refiners Take Downtime

2018-08-04 rigzone
Aug 3 (Reuters) - The discount on Canada's heavy crude, which reached a nearly five-year high this week, looks to remain elevated with pipelines strained and the refiners who buy it going offline for maintenance, industry officials say.
CVE IMO RDS.B RDS.A MEG RDSB RDSA IMO SU RYDBF CVE MEGEF RYDAF SU

1
Canada crude differential seen staying high as refiners take downtime

2018-08-03 reuters
(Reuters) - The discount on Canada’s heavy crude, which reached a nearly five-year high this week, looks to remain elevated with pipelines strained and the refiners who buy it going offline for maintenance, industry officials say.
CVE IMO RDS.B RDS.A MEG RDSB RDSA IMO SU RYDBF CVE MEGEF RYDAF SU

 
Canadian Natural unveils plan to add 100,000 bpd of Horizon oilsands output

2018-08-02 cbc.ca
Canadian Natural Resources Ltd. said Thursday it will spend an additional $170 million this year to advance projects that could add almost 100,000 barrels per day of production at its Horizon oilsands mine in northern Alberta.
IMO CNQ IMO SU SU

5
Imperial Oil Ltd (IMO) CEO Rich Kruger on Q2 2018 Results - Earnings Call Transcript

2018-07-28 seekingalpha - 1
Good day, ladies and gentleman. And welcome to the Imperial 2018 Midyear Update Conference Call. At this time, all participants are in a listen only mode. Later we will conduct a question-and-answer session and instructions will follow at that time [Operator Instructions].
IMO XOM IMO KMI MS KMR CVB KMRFZ

 
Imperial Oil posts $196M profit in 2nd quarter, higher revenue

2018-07-27 cbc.ca
Imperial Oil Ltd. had a $196-million profit in the second quarter and a nearly 36 per cent increase in revenue, marking a turnaround from the loss it experienced a year earlier.
IMO IMO

1
Imperial Oil (IMO) Q2 Earnings Lag Estimates

2018-07-27 zacks
Imperial Oil (IMO - Free Report) just came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.39 per share. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.
IMO NVR IMO TRN

3
Imperial Oil reports profit in second quarter

2018-07-27 reuters
(Reuters) - Canada’s Imperial Oil Ltd (IMO.TO) on Friday reported a profit in the second quarter compared with a year-earlier loss, helped by growth in its refining and chemicals businesses.
IMO XOM IMO

 
Suncor cash flow soothes investor concerns over Syncrude outage

2018-07-26 worldoil
CALGARY (Bloomberg) -- Suncor Energy Inc. managed to largely allay investors’ concerns over the most recent production problem at its massive Syncrude facility by highlighting its increasing cash flow and returning more of those funds to shareholders.
IMO IMO CEO SU SU

6
Oil Stocks to Watch for Earnings on Jul 27: CVX, XOM & IMO

2018-07-26 zacks
With the earnings season gathering steam,a host of companies are expected to report quarterly results by the end of this week. Per the latest Earnings Outlook, 147 S&P 500 members have already reported quarterly results, with their total earnings up 23.3% from the same period last year on 9.1% higher revenues. Notably, 83.7% of the firms surpassed the Zacks Consensus Estimate for earnings, while 74.
SLB IMO XOM IMO KMI CVX SCL SLB KMR CVB KMRFZ

 
Rights tribunal slams Imperial Oil for cancelling job offer to engineer over immigration status

2018-07-26 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
IMO IMO

 
PrairieSky results buoyed by strong oil prices despite poor natural gas prices

2018-07-23 cbc.ca
PrairieSky Royalty Ltd. says strong crude oil prices and volumes in the second quarter allowed it to beat analyst profit expectations despite falling prices and lower production of natural gas.
CVE ECN IMO ECA HUSKF IMO PDS PSK SU HSE ECA CVE PREKF SU

6
5 Energy Stocks Set to Explode Higher

2018-07-11 zacks
The hottest commodity oil has been on a solid run this year thanks to a tightening oil market and rising global demand. Rounds of news about new supply disruption are adding strength to the oil price, making the case for energy stocks appealing. Supply Declining The looming Iran sanctions and falling Libya and Venezuela output were the biggest catalysts in driving oil price lately. The United States is expected to halt oil exports from the fifth-biggest producer Iran by November though some waivers can be granted while production in Libya has halved in five months to 527,000 barrels per day.
APC IMO HFC MUR.WI MUR OXY IMO AEUA

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to TSX:IMO / Imperial Oil on message board site Silicon Investor.

Silicon Motion Inc. (SIMO) Silicon Motion Inc. (SIMO) Silicon Motion Inc. (SIMO) SIMO Busters SIMO Busters SIMO Busters
Simon Property Group, Inc. (SPG) Simon Property Group, Inc. (SPG) Simon Property Group, Inc. (SPG) Imogo Mobile Technologies Corp. Imogo Mobile Technologies Corp. Imogo Mobile Technologies Corp.
PIMO, any thoughts on the stock movements? PIMO, any thoughts on the stock movements? PIMO, any thoughts on the stock movements? Timothy McVeigh Timothy McVeigh Timothy McVeigh
PIMO Recently Signed another Auto-DR Contract PIMO Recently Signed another Auto-DR Contract PIMO Recently Signed another Auto-DR Contract PIMO has one of the most impressive BOD���s for a micro cap PIMO has one of the most impressive BOD���s for a micro cap PIMO has one of the most impressive BOD���s for a micro cap
PIMO Provides Shareholder Update PIMO Provides Shareholder Update PIMO Provides Shareholder Update PIMO Energy Division Secures Another Contract PIMO Energy Division Secures Another Contract PIMO Energy Division Secures Another Contract